A cross‐sectional study on HPV testing with type 16/18 genotyping for cervical cancer screening in 11,064 Chinese women

@inproceedings{Wu2017ACS,
  title={A cross‐sectional study on HPV testing with type 16/18 genotyping for cervical cancer screening in 11,064 Chinese women},
  author={Qiongyan Wu and Xiumin Zhao and Yunfeng Fu and Xinyu Wang and Xiaofei Zhang and Xun Tian and B. T. Cheng and Bing-jian Lu and Xiao Qin Yu and Suqiu Lan and Weiguo Lu and Ding Ma and Xiaodong Cheng and Xing Xie},
  booktitle={Cancer medicine},
  year={2017}
}
Cytology-based cervical cancer screening is restricted because of a lack of cytologists. Thus, HPV-based instead of cytology-based screening may be a more suitable strategy in China. Here, we assessed the effectiveness of HPV testing (Cobas® 4800 Test, Roche) and HPV-based programs to detect high-grade cervical intraepithelial neoplasia (CIN) or cancer… CONTINUE READING